Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice

Medicine & Life Sciences

• 4-(3-3,4-p-menthadien-(1,8)-yl)olivetol 100%
• 2-(2-(4-bromophenyl)-6-methylpyrimidin-4-yl)aminoethanol 99%
• Incretins 65%
• Streptozocin 50%
• Knockout Mice 46%
• Glucose 27%
• Insulin 19%
• Eating 10%
• Gastric Inhibitory Polypeptide 10%
• Body Weight 10%
• Polydipsia 9%
• Glucagon-Like Peptide-1 Receptor 9%
• Peptide Receptors 9%
• Glucagon 7%
• G-Protein-Coupled Receptors 7%
• Intraperitoneal Injections 7%
• Saline Solution 6%
• Oral Administration 6%
• Fatty Acids 6%
• Insulin Resistance 5%
• Triglycerides 5%
• Cholesterol 5%